Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NI Medical’s NICaS system is a non-invasive, FDA-approved and CE-marked hemodynamic monitoring platform used in clinical practice for managing heart failure, hypertension, preeclampsia, dialysis patients, and other cardiovascular conditions. Clinical studies have demonstrated its utility in improving patient outcomes by enabling personalized fluid and cardiac management across various care settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NI Medical.